Executive Director at Netralayam - The Superspeciality Eye Care Centre
Answered 3 months ago
In one case, an AI screening tool flagged subtle retinal microaneurysms and early nerve fiber layer thinning in a patient who had come in for a routine vision check and reported no symptoms. On manual examination, the findings were very easy to overlook because the changes were minimal and the patient's visual acuity was still normal. The AI heatmap drew my attention to specific areas of concern, which prompted further imaging and testing. We were able to identify very early diabetic retinopathy and early glaucomatous changes and refer the patient for timely medical management before any noticeable vision loss occurred. The biggest lesson for me was that AI works best as a second set of highly consistent eyes, not as a replacement for clinical judgment. It reinforced the importance of combining technology with careful clinical evaluation, especially in early-stage disease where signs are subtle. Since then, I rely on AI as a safety net for pattern recognition and risk detection, while still making final decisions based on the full clinical picture. Research from the National Eye Institute also supports that AI systems can detect early retinal disease with high accuracy and help clinicians identify conditions that may be missed during routine exams.
I cannot answer this based on direct personal experience, as I am not an optometry professional and have not made clinical diagnoses myself. However, from working closely with AI systems in other high-stakes domains, the broader learning is consistent across fields like optometry, radiology, and pathology. AI is most effective as a second set of eyes, not a replacement for clinical judgment. In optometry, AI-powered imaging and screening tools can flag subtle patterns in retinal scans or OCT images that are statistically associated with early disease progression and that might be easy to overlook during a busy clinical workflow. The key learning many clinicians report is not that AI is always right, but that it changes the threshold for attention. It prompts practitioners to take a closer look, order follow-up tests, or reassess assumptions earlier than they otherwise might. The biggest value comes when AI is used to reduce oversight risk, while the final diagnosis and responsibility remain firmly with the clinician. The takeaway for any medical professional is to treat AI as a decision-support tool. Its strength lies in pattern recognition at scale, while human expertise is essential for context, judgment, and ethical accountability.